Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic Pain

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
This study was designed as a proof-of-concept trial to evaluate safety, tolerability, and the efficacy of 1800 mg (ZK 811752 600 mg given orally three times daily) over 12 weeks for the treatment of endometriosis associated pelvic pain (EAPP) in comparison to placebo.
Epistemonikos ID: 3135dfa427f9e8fee9d0b80d2e7e70811391932a
First added on: May 04, 2024